Ever-Tenacious Ossur to Ring NASDAQ Closing Bell

ALISO VIEJO, CA, Nov 06 (MARKET WIRE) --
On Monday, November 9, Jon Sigurdsson, president and CEO of Ossur Hf.,
will mark the company's tenth year of trading publically on NASDAQ OMX
Iceland, and also commemorate its new dual listing on NASDAQ OMX
Copenhagen, by ringing the NASDAQ stock market Closing Bell in New York
City.

Ossur is the proud Icelandic developer and manufacturer of non-invasive
orthopaedics that has survived a most challenging year. A global leader in
its category, the company has weathered the storm thanks to its clear
focus on improving people's mobility through the delivery of innovative
technologies within the fields of bracing and supports, prosthetic limbs
and compression therapies.

"Our outlook has always been on a global scale, and this thinking has
served us well," said Mr. Sigurdsson, a World Economic Forum TechPioneer
alumnus. "It is especially fitting that we should celebrate this honor in
the United States, where we have extensive operations and have enjoyed an
increase in sales in the 3rd Quarter of this year," he added. Ossur is
best known as the purveyor of the Cheetah Flex-Foot, the prosthetic
device of choice for elite amputee athletes like Oscar Pistorius who
recently challenged the IAAF for the right to compete against able-bodied
athletes in the Olympics, and won. It is also the first company in the
world to bring bionic prosthetic feet and knees to market, including the
RHEO KNEE, the POWER KNEE, and the PROPRIO FOOT. In the past five years,
Ossur acquired a number of orthopaedic companies, and is renowned for its
proven solution for Knee Osteoarthritis, the Unloader One brace.

About Ossur

Ossur (Nasdaq OMX: OSSR/ OSSR DKK) is a global leader in non-invasive
orthopaedics that help people live a life without limitations. Its
business is focused on improving people's mobility through the delivery of
innovative technologies within the fields of braces, supports, prosthetic
limbs and compression therapies. A recognized "Technology Pioneer," Ossur
invests significantly in research and product development; its
award-winning designs ensuring a consistently strong position in the
market. Successful patient and clinical outcomes are further empowered via
Ossur's educational programs and business solutions. Headquartered in
Iceland, Ossur has major operations in the Americas, Europe and Asia, with
additional distributors worldwide. Website: www.ossur.com

Contacts:

Ossur Investor Relations
Sigurborg Arnarsdottir
Tel.: +354 515 1339
Fax: +354 515 1366
Email Contact
www.ossur.com

Beverly Millson
Public relations for Ossur
Tel: +512 798 7798
Cell: +310 804 3469
Email Contact

Copyright 2009, Market Wire, All rights reserved.

-0-